NN9535-4447 Epidemiological assessment of the risk for pancreatic cancer associated with the use of semaglutide in patients with type 2 diabetes- A cohort study based on Nordic registry data

Documents

Study protocol

Initial protocol

_ Public Registration of Results 4447 protocol eu-pas-reg redacted.pdf

Study results

Study report

Study report

First Progress Report NN9535-4447

Progress report NN9535-4447_3

_ Regulatory Progress Report NN9535-4447 progress report_2

Progress report NN9535-4447_4.pdf

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

This study has been awarded the ENCePP seal

Conflicts of interest of investigators

2020-0065 Declaration of Interests

Composition of steering group and observers

ENCePP Seal Composition of Steering Group and Observers

Signed code of conduct

ENCePPCoCAnnex3_DeclarationofcompliancewiththeENCePPCodeofConduct.pdf

Signed code of conduct checklist

AcroBrwEx_ENCePPCoCAnnex2_ChecklistofCodeofConduct.pdf_ADWC830.tmp_.pdf

Signed checklist for study protocols

ENCePP checklist study protocol v.2.0.14th.April_.2021.pdf